SEC Form D private-offering filing

Endlyz Therapeutics, Inc.

Name: Endlyz Therapeutics, Inc. - new SEC Form D private-offering filing, Boston, MA
Published: 2026-05-07

A new SEC Form D private-offering notice from Boston, MA, a $19,650,393 filer-stated offering target in Biotech. The source filing is one click away.

Endlyz Therapeutics, Inc. site↗ Verified via SEC Form D

Biotechnology company developing small molecule therapeutics targeting the ATP13A2 and ATP10B lysosomal transporters to treat Parkinson's disease and other neurodegenerative diseases

Filed 2026-05-07Filed to raise $19,650,393First money in 2026-03-31Raised so far $17,250,395HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) EarlyCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified endlyz.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.